Neutra Corp. (NTRR) stock
NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Neutra gross margin
Gross margin is gross profit as a percentage of revenue.
Neutra's gross margin for the twelve months ending Oct 31, 2023 was 46.2%. For fiscal 2023 it was 51.9%, against 33.9% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Jan 31, 2023 | 51.9% | +18.1 |
| FY2022 | Jan 31, 2022 | 33.9% | +377.2 |
| FY2021 | Jan 31, 2021 | -343.3% | −443.3 |
| FY2020 | Jan 31, 2020 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | 44.9% | −0.7 |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | 38.9% | −18.1 |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | 48.0% | −5.0 |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | 49.9% | −25.0 |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | 45.7% | +39.4 |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | 57.0% | +60.3 |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | 53.0% | +41.8 |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | 74.9% | +1823.2 |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | 6.3% | −93.7 |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | -3.3% | −79.3 |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | 11.2% | −55.1 |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | -1748.3% | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | 100.0% | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | 76.0% | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | 66.3% | – |
See a number that looks wrong?